BCR and posterior cortical atrophy: The predictive ability of intratumoral MVD for different stages of PCa on BCR was T1‐2 (HR, 2.46; 95% CI, 1.08–5.58; p = 0.03; I2 = 83%), T1‐3 (HR, 2.38, 95% CI, 1.41–4.01; p = 0.001; I2 = 82%), T1‐4 (HR, 1.61; 95% CI, 1.19–2.19; p = 0.002; I2 = 61%).The subgroup analyses based on European and immunohistochemical antibody none‐factor VII were consistent with primary one.